VANESSA BECKER: Open Payments
NPI 1861496440 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 92 payments from 18 companies in 2025. Trend: 2023 $1,291 · 2024 $1,937 · 2025 $1,764
Food & beverage: $1,687Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $414 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $313 |
| Janssen Biotech, Inc. | 14 | $276 |
| Ipsen Biopharmaceuticals, Inc | 5 | $185 |
| Gilead Sciences, Inc. | 4 | $84 |
| Lilly USA, LLC | 4 | $75 |
| Ardelyx, Inc. | 3 | $72 |
| Novo Nordisk Inc | 3 | $54 |
| Celltrion USA Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
Products named: XIFAXAN, TREMFYA, IQIRVO, RINVOQ, LINZESS, OMVOH, IBSRELA, MAVYRET.
Industry payments across TX — which companies pay providers there.
